Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Saved in:
Bibliographic Details
Title: Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Authors: Fizazi K; Department of Medical Oncology, Centre Oscar Lambret, Lille, France; Department of Medical Oncology, University of Paris Saclay, Villejuif, France., Attard G; Research Department of Oncology, University College London, London, UK., Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Baciarello G; Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Bjartell A; Department of Urology, Skåne University Hospital, Malmo, Sweden., Blanchard P; Department of Radiation Oncology, Gustave Roussy, Université Paris Saclay, INSERM U1018 Oncostat, Villejuif, France., Bossaert F; CerHom, Villejuif, France., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Compérat E; Department of Pathology, Medical University of Vienna, Vienna, Austria., de Bono J; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK., Deschamps A; Europa Uomo, The European Prostate Cancer Coalition, Antwerp, Belgium., Efstathiou E; Knight Comprehensive Cancer Center, Oregon Health and Science University, Portland, USA., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia., Fanti S; Department of Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy., Fonteyne V; Department of Radiation Oncology, Ghent University, Ghent, Belgium., González-Del-Alba A; Medical Oncology Department, University Hospital Puerta de Hierro Majadahonda, Madrid, Spain., Gravis G; Department of Medical Oncology, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, CRCM, Aix Marseille University, Marseille, France., James ND; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., McDermott RS; Department of Medical Oncology, St Vincent's University Hospital & University College Dublin, Dublin, Ireland., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Parker C; Urology Unit, The Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK., Renard-Penna RM; Department of Imagery, Hôpital Pitié Salpétrière, Sorbonne Université, Paris, France., Rubin MA; Department for Biomedical Research, University of Bern, Bern, Switzerland., Saad F; Department of Surgery and Urologic Oncology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Canada., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey., Tombal B; Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Tree AC; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK; Uro-Oncology Department, The Royal Marsden Hospital, Sutton, UK., Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Center, Marseille, France., Zilli T; Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano, Switzerland., Gillessen S; Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano, Switzerland; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Corporate Authors: ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 May; Vol. 37 (5), pp. 590-607. Date of Electronic Publication: 2026 Feb 10.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41679466
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fizazi+K%22">Fizazi K</searchLink>; Department of Medical Oncology, Centre Oscar Lambret, Lille, France; Department of Medical Oncology, University of Paris Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Attard+G%22">Attard G</searchLink>; Research Department of Oncology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Azad+AA%22">Azad AA</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Baciarello+G%22">Baciarello G</searchLink>; Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Bjartell+A%22">Bjartell A</searchLink>; Department of Urology, Skåne University Hospital, Malmo, Sweden.<br /><searchLink fieldCode="AU" term="%22Blanchard+P%22">Blanchard P</searchLink>; Department of Radiation Oncology, Gustave Roussy, Université Paris Saclay, INSERM U1018 Oncostat, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Bossaert+F%22">Bossaert F</searchLink>; CerHom, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Castro+E%22">Castro E</searchLink>; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Compérat+E%22">Compérat E</searchLink>; Department of Pathology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22de+Bono+J%22">de Bono J</searchLink>; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Deschamps+A%22">Deschamps A</searchLink>; Europa Uomo, The European Prostate Cancer Coalition, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Efstathiou+E%22">Efstathiou E</searchLink>; Knight Comprehensive Cancer Center, Oregon Health and Science University, Portland, USA.<br /><searchLink fieldCode="AU" term="%22Emmett+L%22">Emmett L</searchLink>; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Fanti+S%22">Fanti S</searchLink>; Department of Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Fonteyne+V%22">Fonteyne V</searchLink>; Department of Radiation Oncology, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22González-Del-Alba+A%22">González-Del-Alba A</searchLink>; Medical Oncology Department, University Hospital Puerta de Hierro Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gravis+G%22">Gravis G</searchLink>; Department of Medical Oncology, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, CRCM, Aix Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22James+ND%22">James ND</searchLink>; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Kanesvaran+R%22">Kanesvaran R</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22McDermott+RS%22">McDermott RS</searchLink>; Department of Medical Oncology, St Vincent's University Hospital & University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Mehra+N%22">Mehra N</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Parker+C%22">Parker C</searchLink>; Urology Unit, The Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK.<br /><searchLink fieldCode="AU" term="%22Renard-Penna+RM%22">Renard-Penna RM</searchLink>; Department of Imagery, Hôpital Pitié Salpétrière, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rubin+MA%22">Rubin MA</searchLink>; Department for Biomedical Research, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Saad+F%22">Saad F</searchLink>; Department of Surgery and Urologic Oncology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Canada.<br /><searchLink fieldCode="AU" term="%22Sweeney+C%22">Sweeney C</searchLink>; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Tilki+D%22">Tilki D</searchLink>; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Tombal+B%22">Tombal B</searchLink>; Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Tree+AC%22">Tree AC</searchLink>; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK; Uro-Oncology Department, The Royal Marsden Hospital, Sutton, UK.<br /><searchLink fieldCode="AU" term="%22Walz+J%22">Walz J</searchLink>; Department of Urology, Institut Paoli-Calmettes Cancer Center, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Zilli+T%22">Zilli T</searchLink>; Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gillessen+S%22">Gillessen S</searchLink>; Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano, Switzerland; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ESMO+Guidelines+Committee%2E+Electronic+address%3A+clinicalguidelines%40esmo%2Eorg%22">ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2026 May; Vol. 37 (5), pp. 590-607. <i>Date of Electronic Publication: </i>2026 Feb 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Practice Guideline
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41679466
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2026.01.015
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 590
    Titles:
      – TitleFull: Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fizazi K
      – PersonEntity:
          Name:
            NameFull: Attard G
      – PersonEntity:
          Name:
            NameFull: Azad AA
      – PersonEntity:
          Name:
            NameFull: Baciarello G
      – PersonEntity:
          Name:
            NameFull: Beltran H
      – PersonEntity:
          Name:
            NameFull: Bjartell A
      – PersonEntity:
          Name:
            NameFull: Blanchard P
      – PersonEntity:
          Name:
            NameFull: Bossaert F
      – PersonEntity:
          Name:
            NameFull: Castro E
      – PersonEntity:
          Name:
            NameFull: Compérat E
      – PersonEntity:
          Name:
            NameFull: de Bono J
      – PersonEntity:
          Name:
            NameFull: Deschamps A
      – PersonEntity:
          Name:
            NameFull: Efstathiou E
      – PersonEntity:
          Name:
            NameFull: Emmett L
      – PersonEntity:
          Name:
            NameFull: Fanti S
      – PersonEntity:
          Name:
            NameFull: Fonteyne V
      – PersonEntity:
          Name:
            NameFull: González-Del-Alba A
      – PersonEntity:
          Name:
            NameFull: Gravis G
      – PersonEntity:
          Name:
            NameFull: James ND
      – PersonEntity:
          Name:
            NameFull: Kanesvaran R
      – PersonEntity:
          Name:
            NameFull: McDermott RS
      – PersonEntity:
          Name:
            NameFull: Mehra N
      – PersonEntity:
          Name:
            NameFull: Parker C
      – PersonEntity:
          Name:
            NameFull: Renard-Penna RM
      – PersonEntity:
          Name:
            NameFull: Rubin MA
      – PersonEntity:
          Name:
            NameFull: Saad F
      – PersonEntity:
          Name:
            NameFull: Sweeney C
      – PersonEntity:
          Name:
            NameFull: Tilki D
      – PersonEntity:
          Name:
            NameFull: Tombal B
      – PersonEntity:
          Name:
            NameFull: Tree AC
      – PersonEntity:
          Name:
            NameFull: Walz J
      – PersonEntity:
          Name:
            NameFull: Zilli T
      – PersonEntity:
          Name:
            NameFull: Gillessen S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1